Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.05 USD | +2.64% | -6.83% | +11.73% |
May. 09 | Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, vs. Street Est of $9.9M | MT |
May. 09 | Transcript : ProPhase Labs, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 54.79M | Sales 2025 * | 138M | Capitalization | 91.13M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | 11M | EV / Sales 2024 * | 1.66 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.66 x |
P/E ratio 2024 * |
-6.12
x | P/E ratio 2025 * |
10.5
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.03% |
Latest transcript on ProPhase Labs, Inc.
1 day | +2.64% | ||
1 week | -6.83% | ||
Current month | +9.54% | ||
1 month | -22.55% | ||
3 months | -2.70% | ||
6 months | +10.99% | ||
Current year | +11.73% |
Managers | Title | Age | Since |
---|---|---|---|
Ted Karkus
CEO | Chief Executive Officer | 64 | 09-06-14 |
Chief Operating Officer | 50 | Dec. 31 | |
Robert Morse
AUD | Comptroller/Controller/Auditor | 49 | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Louis Gleckel
BRD | Director/Board Member | 68 | 09-05-31 |
Ted Karkus
CEO | Chief Executive Officer | 64 | 09-06-14 |
Jason Barr
BRD | Director/Board Member | 44 | 15-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 0 M€ | -2.98% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 5.05 | +2.64% | 32,777 |
24-05-09 | 4.92 | -8.72% | 71,139 |
24-05-08 | 5.39 | +6.52% | 57,288 |
24-05-07 | 5.06 | -5.24% | 15,936 |
24-05-06 | 5.34 | -1.48% | 40,416 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.73% | 91.13M | |
-16.58% | 8.49B | |
+58.90% | 4.08B | |
-39.78% | 2.42B | |
-10.33% | 2.42B | |
-8.91% | 2.33B | |
-2.53% | 2.01B | |
-19.90% | 1.53B | |
-38.30% | 1.26B | |
+2.19% | 1.07B |
- Stock Market
- Equities
- PRPH Stock